Compare HST & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HST | FMS |
|---|---|---|
| Founded | 1927 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Misc Health and Biotechnology Services |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8B | 14.2B |
| IPO Year | 1998 | N/A |
| Metric | HST | FMS |
|---|---|---|
| Price | $19.20 | $23.46 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 14 | 2 |
| Target Price | $18.96 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 8.5M | 615.8K |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.94% | 2.48% |
| EPS Growth | ★ 11.11 | N/A |
| EPS | ★ 1.10 | N/A |
| Revenue | ★ $5,387,000,000.00 | N/A |
| Revenue This Year | N/A | $1.41 |
| Revenue Next Year | $1.19 | $4.11 |
| P/E Ratio | $17.49 | ★ $15.62 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.27 | $20.96 |
| 52 Week High | $21.00 | $30.46 |
| Indicator | HST | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 46.20 | 50.58 |
| Support Level | $17.15 | $23.38 |
| Resistance Level | $21.00 | $24.08 |
| Average True Range (ATR) | 0.65 | 0.43 |
| MACD | -0.13 | -0.09 |
| Stochastic Oscillator | 27.94 | 46.78 |
Host Hotels & Resorts owns 80 predominantly urban and resort upper-upscale and luxury hotel properties representing nearly 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.